研究等業績 - その他 - 和田 優貴
-
Naoko Mori, Yuki Wada, Satoshi Kumagai, Yu Mori, Hiroshi Sakamoto, Shunji Mugikura
Japanese Journal of Radiology ( Springer Science and Business Media LLC ) 2025年04月
-
So Kodama, Kenta Watanabe, Tamotsu Matsuhashi, Sho Fukuda, Yosuke Shimodaira, Yushi Nagaki, Akiyuki Wakita, Yusuke Sato, Tomoki Tozawa, Yuki Wada, Naoko Mori, Hiroshi Nanjo, Katsunori Iijima
Esophagus ( Esophagus ) 2025年03月 [査読有り]
-
「課題先進県」の秋田県で考えるこれからの放射線治療
和田優貴
JASTRO NEWSLETTER 155 ( 1 ) 37 - 39 2025年03月
その他記事 単著
-
Yuki Wada, Naoko Mori
International Journal of Radiation Oncology Biology Physics ( International Journal of Radiation Oncology Biology Physics ) 120 ( 3 ) 2024年11月 [査読有り]
速報,短報,研究ノート等(学術雑誌) 国内共著
-
緩和照射普及のための秋田大学放射線治療科での取組みと工夫
和田優貴
JASTRO NEWSLETTER 152 ( 152 ) 38 - 39 2024年06月
その他記事 単著
-
胸部X線画像の診方 -理学療法士の立場から-
大倉和貴, 和田優貴
秋田理学療法 31 ( 1 ) 11 - 17 2024年03月 [査読有り]
速報,短報,研究ノート等(大学,研究機関紀要) 国内共著
-
放射線治療部門の水害対策 秋田豪雨の経験から
和田優貴
JASTRO NEWSLETTER 150 ( 150 ) 24 - 25 2023年12月
その他記事 単著
-
Yuki Wada, Tetsugaku Shinozaki, Toshiki Murata, Satoshi Kumagai, Noriko Takagi, Naoko Mori
Advances in Radiation Oncology ( Elsevier BV ) 8 ( 5 ) 101293 - 101293 2023年09月 [査読有り]
速報,短報,研究ノート等(学術雑誌) 国内共著
-
Re.: “A Systematic Review of the Safety and Efficacy of Stenting of the Inferior Vena Cava”
Noriko Takagi, Yuri Wada, Naoko Mori
European Journal of Vascular and Endovascular Surgery ( Elsevier BV ) 66 ( 2 ) 2023年04月 [査読有り]
速報,短報,研究ノート等(学術雑誌)
-
Yuki Wada, Naoko Mori
Gastroenterology ( Elsevier BV ) 165 ( 2 ) 518 - 519 2022年11月 [査読有り]
速報,短報,研究ノート等(学術雑誌) 国内共著
-
Yuki Wada, Akira Anbai, Noriko Takagi, Tomoki Tozawa, Satoshi Kumagai, Eriko Okuyama, Kento Hatakeyama, Makoto Niwa, Manabu Hashimoto
Akita Journal of Medicine ( 秋田医学会 ) 48 ( 5 ) 47 - 53 2021年11月
The rare condition of brachial plexus metastasis (BPM) from malignant carcinoma causes extreme pain and can limit activities of daily living. A few reports have indicated that palliative irradiation is an effective and safe treatment for BPM ; however, the efficacy and safety of reirradiation for BPM are not well-known. In the present report, we describe the case of a patient with BPM of breast cancer who had a history of receiving 60 Gy of irradiation in 30 fractions to bilateral subclavian areas to treat lymph node metastases, developed extremely painful BPM in the primary irradiated area, and underwent further irradiation with 20 Gy in five fractions. This palliative reirradiation initially resulted in significant pain relief, and the tumors reduced in size immediately after the treatment. Regrowth of the tumors and recurrence of the pain occurred five months after irradiation ; however, further irradiation was not administered as it could be associated with a high risk of plexopathy or myelopathy. This case report describes the tolerability and effectiveness of reirradiation for BPM, the decision process of reirradiation, and the usefulness of modern diagnostic imaging for deciding radiation field and technique to deliver safe and effective reirradiation.
-
Selective transcatheter arterial infusion of cisplatin in palliative intent for residual bulky tongue cancers after intravenous systemic chemotherapy combined with radiotherapy: Two case reports
Yuki Wada, Aoi Otaka, Takaharu Miyauchi, Naoko Fukui, Hiromoto Kimura, Manabu Hashimoto
Journal of Clinical Images and Medical Case Reports 2 ( 5 ) 1333 2021年09月
-
高齢者における食道癌手術の現状と課題 高齢患者に対する食道切除術の有効性に関する検討(Analysis whether esophagectomy provides advantages for elderly patients)
脇田 晃行, 本山 悟, 佐藤 雄亮, 藤田 啓, 煙山 紘平, 安倍 明, 和田 優貴, 南谷 佳弘
日本食道学会学術集会プログラム・抄録集 ( (NPO)日本食道学会 ) 75回 57 - 57 2021年09月
-
Takeshima M.
Vascular Health and Risk Management ( Vascular Health and Risk Management ) 17 239 - 246 2021年
-
Yuki Wada, Akira Anbai, Noriko Takagi, Satoshi Kumagai, Eriko Okuyama, Hiroshi Nanjo, Yusuke Sato, Satoru Motoyama, Manabu Hashimoto
Cancers ( MDPI AG ) 13 ( 1 ) 8 - 8 2020年12月
The differences in prognoses or progression patterns between T4b non-N4 and non-T4b N4 esophageal squamous cell carcinoma post chemoradiotherapy (CRT) is unclear. This study compared the outcomes of CRT for stage IVa esophageal squamous cell carcinoma according to T/N factors. We retrospectively identified 66 patients with stage IVa esophageal squamous cell carcinoma who underwent definitive CRT at our center between January 2009 and March 2013. The treatment outcomes, i.e., progression patterns, prognostic factors, and toxicities based on version 5.0 of the National Cancer Institute Common Terminology Criteria for Adverse Events, were studied. The patients (56 men and 10 women) had a median age of 67 (range: 37–87) years. The T/N classifications were T4b non-N4 (28/66), non-T4b N4 (24/66), and T4b N4 (14/66). Objective response was achieved in 57 patients (86.4%, (95% confidence interval, 74.6–94.1%)). There were no significant differences between the T/N groups in terms of overall survival, progression-free survival, and progression pattern. We found no significant differences in prognoses or progression patterns among patients with T4b non-N4, non-T4b N4, and T4b N4 esophageal squamous cell carcinoma. Thus, it seems impractical to modify CRT regimens based on T/N factors.
-
Wada Y.
Translational Cancer Research ( Translational Cancer Research ) 9 ( 8 ) 5077 - 5086 2020年08月
-
Yuki Wada, Manabu Hashimoto
Translational Cancer Research ( AME Publishing Company ) 9 ( 8 ) 5077 - 5086 2020年08月
-
YC-1 sensitizes the antitumor effects of boron neutron capture therapy in hypoxic tumor cells
Harada T.
Journal of radiation research ( Journal of radiation research ) 61 ( 4 ) 524 - 534 2020年07月
-
COVID-19パンデミックにおける放射線治療 提言
JASTRO COVID, 対策アドホック委員会, コロナ対策実行グループ
https://jastro-covid19.net/data/jastro_covid19_proposal_1_1.pdf 2020年05月
-
前立腺癌に対する密封小線源療法におけるPSA低下率の臨床的意義
小林 瑞貴, 沼倉 一幸, 武藤 弓奈, 佐藤 博美, 小泉 淳, 奈良 健平, 神田 壮平, 齋藤 満, 成田 伸太郎, 井上 高光, 佐藤 滋, 羽渕 友則, 熊谷 聡, 和田 優貴, 安倍 明
日本癌治療学会学術集会抄録集 ( (一社)日本癌治療学会 ) 57回 P108 - 4 2019年10月
-
Makoto Sugawara, Koichi Ishiyama, Satoshi Takahashi, Takahiro Otani, Makoto Koga, Osamu Watanabe, Masazumi Matsuda, Tomoyuki Asano, Noriko Takagi, Tomoki Tozawa, Yuki Wada, Aoi Otaka, Satoshi Kumagai, Motoko Sasajima, Manabu Hashimoto
Japanese Journal of Radiology ( Springer Science and Business Media LLC ) 37 ( 9 ) 666 - 667 2019年09月
Whereas in FWDCs, a significantly larger volume and lower density of fluid in the paranasal sinuses (P = 0.0195 and P = 0.0104, respectively), lower density of fluid in the central airways (P = 0.0077), lower stomach content density (P = 0.0216), lower density in the left atrium (P = 0.0029), and a difference of density between the atria (P = 0.0019) were observed.
-
Sugawara M.
Japanese Journal of Radiology ( Japanese Journal of Radiology ) 37 ( 9 ) 666 - 667 2019年09月
-
Wada Y.
Radiation Oncology ( Radiation Oncology ) 14 ( 1 ) 1 - 7 2019年06月
Background: Determining the appropriate gross tumor volume is important for irradiation planning in addition to palliative radiation for bone metastases. While irradiation planning is commonly performed using simulation computed tomography (CT), magnetic resonance imaging (MRI), bone scintigraphy, and 18fluorodeoxyglucose-positron emission tomography-CT (18FDG-PET-CT) are more sensitive for detecting bone metastasis and invasion areas. Therefore, this study evaluated whether pretreatment imaging modalities influenced the response to palliative radiation therapy (i.e., the irradiation effect) for painful bone metastases from solid malignant carcinomas. Methods: Consecutive patients with painful bone metastases treated with palliative radiation between January 2013 and December 2017 at our institution were included. We retrospectively investigated the pretreatment images from the different imaging modalities (CT, MRI, bone scintigraphy, and 18FDG-PET-CT) obtained between 1 month before and the initiation of palliative radiation and determined the primary site of carcinoma, histological type, metastatic lesion type (osteolytic, osteoblastic, or mixed), pathological fracture, and metastatic site (vertebral or not). We then evaluated the relationship between these factors and treatment response. We defined "response" as the condition in which patients achieved pain relief or reduced the use of painkiller medicines. Results: In total, 131 patients (78 men and 53 women) were included; the median age was 66 years (range, 24-89 years). Prescribed doses were 8-50 Gy/1-25 fractions with 2-8 Gy/fraction. Among the 131 patients, 105 were responders (response rate, 80%). The imaging modalities performed before irradiation were CT in 131 patients, MRI in 54, bone scintigraphy in 56, and 18FDG-PET-CT in 14. The Welch t-test and chi-square test showed no significant association between treatment response and each factor. Multiple logistic regression analysis including the imaging modality, metastatic site, and pathological fracture also showed no significant association with each factor. Conclusions: There was no significant relationship between the type of pretreatment imaging and treatment response for painful bone metastases. Thus, setting the appropriate radiation field according to CT images and clinical findings could help avoiding further image inspection before palliative radiation for painful bone metastases.
-
乳房原発悪性リンパ腫に逐次的化学放射線療法を施行して長期完全寛解を得ている1例
熊谷 聡, 和田 優貴, 笹嶋 素子, 高木 倫子, 安倍 明, 橋本 学, 亀岡 吉弘, 南條 博
Japanese Journal of Radiology ( (公社)日本医学放射線学会 ) 37 ( Suppl. ) 12 - 12 2019年02月
-
熊谷優, 赤嶺由美子, 安倍明, 和田優貴, 戸沢智樹, 笹嶋素子, 熊谷聡, 橋本学, 三浦昌朋
日本病院薬剤師会雑誌 ( (一社)日本病院薬剤師会 ) 55 ( 7 ) 805 - 812 2019年
シスプラチンの腎毒性発現リスクはカルシウム拮抗薬(calcium channel blocker:以下、CCB)との併用によって増強されることが動物にて報告されているが、ヒトでの報告は少ない。今回、シスプラチン投与食道がん患者の腎機能に及ぼす降圧剤の影響を調査した。食道がん放射線化学療法施行患者のうち、降圧剤併用群42名、非併用群71名を調査対象とした。CCB併用群およびアンジオテンシンII受容体拮抗薬(angiotensin II receptor blocker:以下、ARB)あるいはアンジオテンシン変換酵素阻害薬(angiotensin-converting-enzyme inhibitor:以下、ACEI)併用群は非併用群と比べて急性腎障害(acute kidney injury:以下、AKI)の発現頻度が有意に高く(それぞれp=0.001、p=0.011)、またAKI発現時期はシスプラチン治療開始後7日目で最も高かった。シスプラチンと降圧剤の併用によって、AKI発現リスクが高まる可能性が示唆された。シスプラチン治療開始前にCCB、ARBおよびACEI以外の薬剤への変更を提案することが望まれるが、降圧剤使用継続の際は早期からの血液検査のモニタリングが必要と考える。(著者抄録)
-
Takagi N, Anbai A, Wada Y, Kumagai S, Okuyama E, Hatakeyama K, Hashimoto M
Akita Journal of Medicine 46 ( 3-4 ) 79 - 90 2019年
-
Embosphereを用いた術前塞栓術を施行した頭頸部腫瘍における組織学的検討
松田雅純, 高橋聡, 大谷隆浩, 戸沢智樹, 和田優貴, 菅原真人, 石山公一, 橋本学, 国分康平, 清水宏明, 山崎一春, 山田武千代, 南條博
Japanese Journal of Radiology 37 ( Supplement ) 2019年
-
局所進行食道癌に対する治療戦略 局所進行食道癌に対する我々の治療戦略 化学放射線療法および食道切除
本山 悟, 佐藤 雄亮, 脇田 晃行, 川北 雄太, 長岐 雄志, 南谷 佳弘, 安倍 明, 和田 優貴
日本癌治療学会学術集会抄録集 ( (一社)日本癌治療学会 ) 56回 SY18 - 4 2018年10月
-
Yuki Wada, Katsumi Hirose, Takaomi Harada, Mariko Sato, Tsubasa Watanabe, Akira Anbai, Manabu Hashimoto, Yoshihiro Takai
Journal of Radiation Research ( Oxford University Press (OUP) ) 59 ( 2 ) 122 - 128 2018年03月
Boron neutron capture therapy (BNCT) can potentially deliver high linear energy transfer particles to tumor cells without causing severe damage to surrounding normal tissue, and may thus be beneficial for cases with characteristics of infiltrative growth, which need a wider irradiation field, such as glioblastoma multiforme. Hypoxia is an important factor contributing to resistance to anticancer therapies such as radiotherapy and chemotherapy. In this study, we investigated the impact of oxygen status on 10B uptake in glioblastoma cells in vitro in order to evaluate the potential impact of local hypoxia on BNCT. T98G and A172 glioblastoma cells were used in the present study, and we examined the influence of oxygen concentration on cell viability, mRNA expression of L-amino acid transporter 1 (LAT1), and the uptake amount of 10B-BPA. T98G and A172 glioblastoma cells became quiescent after 72 h under 1% hypoxia but remained viable. Uptake of 10B-BPA, which is one of the agents for BNCT in clinical use, decreased linearly as oxygen levels were reduced from 20% through to 10%, 3% and 1%. Hypoxia with <10% O2 significantly decreased mRNA expression of LAT1 in both cell lines, indicating that reduced uptake of 10B-BPA in glioblastoma in hypoxic conditions may be due to reduced expression of this important transporter protein. Hypoxia inhibits 10B-BPA uptake in glioblastoma cells in a linear fashion, meaning that approaches to overcoming local tumor hypoxia may be an effective method of improving the success of BNCT treatment.
-
食道がん患者におけるシスプラチンと降圧薬併用による腎機能への影響
熊谷優, 赤嶺由美子, 安倍明, 和田優貴, 戸沢智樹, 笹嶋素子, 熊谷聡, 橋本学, 三浦昌朋
日本医療薬学会年会講演要旨集(Web) 28 2018年
-
局所進行食道癌に対する化学放射線療法および手術治療
本山悟, 佐藤雄亮, 脇田晃行, 川北雄大, 長岐雄志, 和田優貴, 安倍明
癌の臨床 64 ( 4 ) 243 - 250 2018年
-
術後リンパ漏に対するリンパ節リンパ管造影の検討
石山 公一, 古賀 誠, 浅野 友之, 菅原 真人, 戸沢 智樹, 和田 優貴, 橋本 学, 劉 嘉嘉, 佐藤 雄亮, 本山 悟
IVR: Interventional Radiology ( (一社)日本インターベンショナルラジオロジー学会 ) 32 ( Suppl. ) 306 - 306 2017年04月
-
Unruptured giant aneurysm of the inferior pancreaticoduodenal artery with superior mesenteric artery stenosis obstructed by spontaneous thrombosis after superior mesenteric artery angioplasty: a case report.
Yuki Wada, Satoshi Takahashi, Makoto Koga, Katsuhito Seki, Manabu Hashimoto
Interventional Radiology ( 一般社団法人 日本インターベンショナルラジオロジー学会 ) 1 ( 2 ) 53 - 58 2017年03月
<p>Most pancreaticoduodenal artery aneurysms involve celiac trunk stenosis or occlusion. Few cases have been related to superior mesenteric artery (SMA) stenosis, and none of these was treated with SMA angioplasty before transcatheter arterial embolization (TAE) or operative resection of the aneurysm. We treated a 79-year-old woman with incidentally detected inferior pancreaticoduodenal artery aneurysms, presumably secondary to SMA stenosis. Abdominal angiography indicated that TAE of the aneurysms would disturb collateral flow and cause SMA ischemia, so SMA angioplasty was performed before TAE of the aneurysms. Arteriography of the SMA six days after angioplasty revealed partial thrombosis in the giant aneurysm. The smaller aneurysm was then embolized to occlude collateral flow, which facilitated further thrombosis of the giant aneurysm without recurrence.</p>
-
Evaluation of the CT angiogram sign and its relationship with the pathological finding of resected primary solid lung cancer in light of modern advances in the technology of CT scanners.
Wada Yuki, Ishiyama Kouichi, Tozawa Tomoki, Otaka Aoi, Takagi Noriko, Asano Tomoyuki, Sugawara Makoto, Nanjo Hiroshi, Saito Hajime, Minamiya Yoshihiro, Hashimoto Manabu
Akita Journal of Medicine 44 ( 3 ) 139 - 146 2017年 [査読有り]
-
海綿静脈洞部硬膜動静脈瘻の経静脈性塞栓術における蝶形頭頂静脈洞造影の有用性
高橋聡, 大谷隆浩, 古賀誠, 戸沢智樹, 和田優貴, 松田雅純, 橋本学, 国分康平, 柳澤俊晴, 清水宏明
日本神経放射線学会プログラム・抄録集 46th 2017年
-
切除不能甲状腺原発扁平上皮癌に対してlenvatinibに放射線外照射を併用し良好な局所制御が得られた1例
和田優貴、安倍明、髙木倫子、高橋絵梨子、寺田かおり、伊藤亜樹、南條博、橋本学
臨床放射線 61 ( 7 ) 953 - 958 2016年07月 [査読有り]
研究論文(その他学術会議資料等) 国内共著
-
当院救命救急センターにおける死後CT検査の有用性の検討
和田優貴、宮内孝治、橋本学
秋田赤十字病院医学雑誌 3 ( 1 ) 8 - 11 2015年04月 [査読有り]
研究論文(その他学術会議資料等) 国内共著
-
外傷性頭蓋内出血に及ぼす抗血栓薬と易転倒性の影響
和田優貴、照井元、西巻啓一、五十嵐厳、岩谷真人、青木勇
日赤医学 64 ( 2 ) 406 - 409 2013年09月 [招待有り]
研究論文(その他学術会議資料等) 国内共著